QHSLab, Inc. Reiterates Its 2022 Projection of a $7.5 Billion Addressable Market for Its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors focused on the digital health community, many of which are currently witnessing
Litchfield Hills Research Weighs in on QHSLab, Inc.'s Q2 2023 Earnings (OTCMKTS:USAQ)
QHSLab, Inc. (OTCMKTS:USAQ – Get Rating) – Equities researchers at Litchfield Hills Research issued their Q2 2023 earnings estimates for shares of QHSLab in a report issued on Friday, December 2nd
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations From the U.S. Preventive Services Task Force
The latest recommendations from the U.S. Preventive Services Task Force (USPSTF) indicate that all adults under the age of 65 be screened for anxiety and depression in primary care including children
QHSLab, Inc. Launches a “Long COVID” Digital Health Tool for Primary Care Physicians
Primary care physicians now have access to reimbursable digital tools for the routine assessment of post-COVID conditions Strengthening QHSLab's Business Model and Expanding Digital Health Product Por
QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services
This Partnership Expands QHSLab's Independent Practitioner Network, While Addressing Current Industry Pain Points. WEST PALM BEACH, FL, June 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ),
QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
WEST PALM BEACH, FL, May 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through
New $90 million annual addressable market for QHSLab's latest product, the Allergy Quick Test, branded AllergiQT™.
WEST PALM BEACH, FL, May 10, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB:USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging point of care technologies, projects a new $90
QHSLab. Issues Update and Investor Presentation May 2022
Superior Business Model and Strategic Position Validated By Repeat Ordering Client Base and New Developments to Product Portfolio Addressable Market Opportunity Includes Over 250,000 Independent Primary Care Physicians Favorably A
USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.
The name change comes from the strong brand recognition garnered by the company's flagship product, QHSLab WEST PALM BEACH, FL, April 19, 2022 (GLOBE NEWSWIRE) -- USA Equities Corp (USAQ: OTCQB) has
USA Equities Corp. A reports Q4 results
USA Equities Corp. A press release (OTCQB:USAQ): Q4 Gross profit of $0.17M Revenue of $0.33M (+265% Y/Y).
No Stock Yet